Login
Need to Register?   Forgot Password?
On-Demand Activities

The Role of Nonpharmacologic and Lipid-Lowering Therapies in a Patient With Low Framingham-Assessed Cardiovascular Risk The Role of Nonpharmacologic and Lipid-Lowering Therapies in a Patient With Low Framingham-Assessed Cardiovascular Risk
NEW! This CME-certified activity offeres the latest evidence-based information on nonpharmacologic and lipid-lowering treatments for a patient with evidence of increased cardiovascular risk beyond that suggested by Framingham Risk Scoring.

Incorporating Novel Means of Risk Assessment in Lipid Management Incorporating Novel Means of Risk Assessment in Lipid Management

This CME-certified activity offers the latest evidence-based information on the management and treatment of a patient who, because of evidence of subclinical atherosclerosis, is at higher CVD risk than that calculated by Framingham Risk Scoring.

.